Alseres Pharmaceuticals, Inc.
Alseres Pharmaceuticals, Inc. (ALSE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALSE · as of Jun 9, 2026
Key Statistics
Explore Alseres Pharmaceuticals, Inc. Data
alse stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
alse competitorsALSE
ACHKF
AGFAF
AQQRF
ELVAY
FLURFStock Performance
Full HistoryAbout Alseres Pharmaceuticals, Inc.
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compo…
what is alseres pharmaceuticals, inc. · alse stock overview · alseres pharmaceuticals, inc. company profile · who is alseres pharmaceuticals, inc. ceo · alse OTC · alseres pharmaceuticals, inc. headquarters · alseres pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Alseres Pharmaceuticals, Inc. (ALSE) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 22, 1994. As of the latest trading session, ALSE stock price is $0.01, with a market capitalization of $398,255. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2013, Alseres Pharmaceuticals, Inc. reported revenue of $473730.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alseres Pharmaceuticals, Inc. (ALSE) stock price is $0.01. The stock is traded on OTC under the ticker symbol ALSE. The 52-week range is $0.01 – $0.01.